Insight into Metabolic <sup>1</sup>H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions.

Front Neurol · 2017 · PMC5591840 · PMID 28928709

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The Kruskal–Wallis tests showed highly significant differences between the subgroups for NAA/Cr, NAA/Cho, Cho/Cr, and Lip/Cr.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.